Regarding aprepitant all are true except:
**Core Concept**
Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist used in the prevention of chemotherapy-induced nausea and vomiting (CINV). It works by blocking the emetic effects of substance P. The mechanism of action involves the inhibition of the NK1 receptor in the central nervous system.
**Why the Correct Answer is Right**
Since the options are not provided, let's discuss the general properties of aprepitant. Aprepitant has a high affinity for the NK1 receptor, which is widely distributed in the central nervous system, particularly in areas involved in emesis. By blocking these receptors, aprepitant prevents the transmission of signals that trigger nausea and vomiting.
**Why Each Wrong Option is Incorrect**
Without the specific options, it's challenging to address each one directly. However, common misconceptions about aprepitant might include its mechanism of action, its use in clinical practice, or its side effect profile.
**Clinical Pearl / High-Yield Fact**
A key point to remember about aprepitant is its role in the prevention of acute and delayed chemotherapy-induced nausea and vomiting, particularly when used in combination with other antiemetic agents. This combination therapy is crucial for improving the quality of life in patients undergoing chemotherapy.
**Correct Answer:**